Monopar Therapeutics Inc. Common Stock (MNPR) is a publicly traded Healthcare sector company. As of May 20, 2026, MNPR trades at $57.95 with a market cap of $376.82M and a P/E ratio of -29.81. MNPR moved -1.64% today. Year to date, MNPR is -16.38%; over the trailing twelve months it is +49.59%. Its 52-week range spans $4.50 to $105.00. Analyst consensus is strong buy with an average price target of $113.00. Rallies surfaces MNPR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
MNPR financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. MNPR recently traded at $57.95. Market cap is $376.82M. P/E ratio is -29.81. Revenue is $0.
| Metric | Value |
|---|---|
| Price | $57.95 |
| Market Cap | $376.82M |
| P/E Ratio | -29.81 |
| EPS | $-1.85 |
| Dividend Yield | 0.00% |
| 52-Week High | $105.00 |
| 52-Week Low | $4.50 |
| Volume | 235.59K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-13.72M |
| Gross Margin | 0.00% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $0 | $-13.72M | $-1.85 |
| 2024 | $0 | $-15.59M | $-4.11 |
| 2023 | $429.04K | $-8.40M | $-0.61 |
| 2022 | $21.24K | $-10.52M | $0.00 |
7 analysts cover MNPR: 0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $113.00.